Arizona Introduces SB 1005 to Ban Cosmetic Animal Testing

Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Jennifer Porter, BA Psychology, MBA – President & CEO

Having started at Focal Point Research in 2011, Jenn has been fully engaged in the company and since day one, has leveraged her MBA and interest in the regulated products industries to grow her passion for the business and services offered.

Jenn has excelled at building on initial conversations with a variety of companies from all industries seeking regulatory and quality assurance services. She has developed strong relationships with each client, offering each one a unique opportunity to have the Focal Point Research team help them develop successful strategies and bring products to market, while ensuring their compliance needs are being fulfilled.

Jenn has not only been a leader internally, but a key contact for all clients and in 2021, Jenn was the obvious choice to lead Focal Point Research into the future as the successor to company founder, Rob Fichtner.

Jennifer balances her career by honouring her wanderlust, spending her leisure time golfing, and enjoying the outdoors with her loving dog.

The landscape of cosmetic regulation in the United States continues to evolve. The Arizona State Senate has officially introduced SB 1005, a bill that seeks to prohibit the use of animal testing for cosmetic products within the state. If enacted, this legislation would mark a significant shift for manufacturers and suppliers operating in or selling to the Arizona market.

Key Provisions of the Bill

The Core Ban: The bill prohibits animal testing specifically for cosmetics.

Effective Date: The proposed ban is set to take effect on December 31, 2026, giving the industry a transition period to adapt to new compliance standards.

Important Exceptions: To accommodate global trade requirements and multi-use chemical regulations, SB 1005 outlines specific exceptions where animal testing would still be permitted:

Foreign Mandates: Testing that is specifically mandated by foreign regulatory authorities remains an exception.
Non-Cosmetic Ingredients: Testing performed on ingredients that are intended for use in non-cosmetic products is excluded from the ban.

What This Means for the Industry This move by Arizona mirrors a growing trend across the country as more states move toward cruelty-free legislative frameworks. Brands selling in Arizona should begin reviewing their supply chains and testing protocols in anticipation of the 2026 deadline.

Delsie Braganza

Jennifer Porter, BA Psychology, MBA – President & CEO

Arizona Introduces SB 1005 to Ban Cosmetic Animal Testing

Recent Posts

Recent Comments

Archives

Categories